News
An Oral Antibiotic Pill Proved Just as Effective as IV Treatment for Drug-Resistant UTIs
A clinical trial found oral fosfomycin as effective as IV carbapenem for drug-resistant UTIs from ESBL bacteria. Here's what the finding means for patients and prescribers.
→
COVID Vaccine Was Linked to 82% Lower Risk of a Rare but Serious Eye Condition
COVID vaccine was linked to 82% lower risk of new-onset uveitis in a new study. HPV, varicella, and herpes zoster vaccines also showed 50%+ risk reduction. Here's what the research found.
→
A New Drug Just Became the First Approved for Both Active and Chronic Thyroid Eye Disease
FDA approved veligrotug (Lumvoa) for both active and chronic thyroid eye disease — a first. Here's who qualifies, what the evidence shows, and what changes for the 50,000–100,000 Americans affected annually.
→
